View in EDS

Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer.

Saved in:
Bibliographic Details
Title: Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer.
Authors: Cavalcanti-Neto MP; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA; Institute of Biodiversity and Sustainability of Macaé, Federal University of Rio de Janeiro, Macaé, Rio de Janeiro, Brazil., Brauer VS; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., Rella A; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., Shamseddine A; Department of Medicine, Stony Brook University, Stony Brook, New York, USA; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA., Dasilva D; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., Matos GS; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., de Sa NP; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., Shroyer K; Department of Pathology, Stony Brook University, Stony Brook, New York, USA., Hannun Y; Department of Medicine, Stony Brook University, Stony Brook, New York, USA; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA; Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, USA., Del Poeta M; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA; Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, USA; United States Department of Veterans Affairs, VA Medical Center, Northport, NY, USA. Electronic address: maurizio.delpoeta@stonybrook.edu.
Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2026 Aug; Vol. 201, pp. 119653. Date of Electronic Publication: 2026 Jun 12.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42284886
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cavalcanti-Neto+MP%22">Cavalcanti-Neto MP</searchLink>; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA; Institute of Biodiversity and Sustainability of Macaé, Federal University of Rio de Janeiro, Macaé, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Brauer+VS%22">Brauer VS</searchLink>; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.<br /><searchLink fieldCode="AU" term="%22Rella+A%22">Rella A</searchLink>; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.<br /><searchLink fieldCode="AU" term="%22Shamseddine+A%22">Shamseddine A</searchLink>; Department of Medicine, Stony Brook University, Stony Brook, New York, USA; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA.<br /><searchLink fieldCode="AU" term="%22Dasilva+D%22">Dasilva D</searchLink>; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.<br /><searchLink fieldCode="AU" term="%22Matos+GS%22">Matos GS</searchLink>; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.<br /><searchLink fieldCode="AU" term="%22de+Sa+NP%22">de Sa NP</searchLink>; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.<br /><searchLink fieldCode="AU" term="%22Shroyer+K%22">Shroyer K</searchLink>; Department of Pathology, Stony Brook University, Stony Brook, New York, USA.<br /><searchLink fieldCode="AU" term="%22Hannun+Y%22">Hannun Y</searchLink>; Department of Medicine, Stony Brook University, Stony Brook, New York, USA; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA; Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, USA.<br /><searchLink fieldCode="AU" term="%22Del+Poeta+M%22">Del Poeta M</searchLink>; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA; Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, USA; United States Department of Veterans Affairs, VA Medical Center, Northport, NY, USA. Electronic address: maurizio.delpoeta@stonybrook.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228213295%22">Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie</searchLink> [Biomed Pharmacother] 2026 Aug; Vol. 201, pp. 119653. <i>Date of Electronic Publication: </i>2026 Jun 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Editions+Scientifiques+Elsevier%22">Editions Scientifiques Elsevier </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>8213295 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1950-6007 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207533322%22">07533322 </searchLink><i>NLM ISO Abbreviation: </i>Biomed Pharmacother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42284886
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.biopha.2026.119653
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 119653
    Titles:
      – TitleFull: Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cavalcanti-Neto MP
      – PersonEntity:
          Name:
            NameFull: Brauer VS
      – PersonEntity:
          Name:
            NameFull: Rella A
      – PersonEntity:
          Name:
            NameFull: Shamseddine A
      – PersonEntity:
          Name:
            NameFull: Dasilva D
      – PersonEntity:
          Name:
            NameFull: Matos GS
      – PersonEntity:
          Name:
            NameFull: de Sa NP
      – PersonEntity:
          Name:
            NameFull: Shroyer K
      – PersonEntity:
          Name:
            NameFull: Hannun Y
      – PersonEntity:
          Name:
            NameFull: Del Poeta M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2026 Aug
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1950-6007
          Numbering:
            – Type: volume
              Value: 201
          Titles:
            – TitleFull: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
              Type: main
ResultId 1